Brief: Amphastar Announces FDA Approval for Teriparatide Injection
15/12/2025 11:22
Dec 15 (Reuters) - Amphastar Pharmaceuticals Inc AMPH.O: AMPHASTAR PHARMACEUTICALS INC: FDA APPROVAL FOR TERIPARATIDE INJECTION AMPHASTAR PHARMACEUTICALS: FDA DETERMINED THAT CO'S TERIPARATIDE IS BIOEQUIVALENT & THERAPEUTICALLY EQUIVALENT TO ELI LILLY'S FORTEO AMPHASTAR PHARMACEUTICALS INC: PLANS TO LAUNCH ITS TERIPARATIDE INJECTION BY END OF YEAR Further company coverage: AMPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray